[company_age]14.0[/company_age][employees]51-200 employees[/employees][funding]Series C[/funding][description]iSTAR Medical is a medtech company specializing in minimally invasive implants for glaucoma surgery. Their mission is to become the world leader in this field. The company's flagship product, MINIject®, is a novel MIGS device made of a unique bio-integrating material called STAR®. MINIject® is designed to enhance natural fluid outflow, reducing intraocular pressure (IOP) and the need for medication. It is currently approved for sale in the European Union, the UK, Switzerland, and Australia. iSTAR Medical is conducting clinical trials in the United States and aims to seek market approval there. The company is headquartered in Switzerland and has offices in the United States and Germany. \n\nWhat sets iSTAR Medical apart from its competitors is its focus on bio-integrating materials. The company's STAR® material is designed to minimize inflammation and fibrosis, potentially leading to better long-term efficacy and safety compared to other MIGS devices. iSTAR Medical is also committed to developing a pipeline of best-in-class products to establish new treatment paradigms in eye care conditions with the highest patient needs.[/description][ps]MINIject® - a minimally invasive glaucoma surgery (MIGS) implant[/ps]